Presenting Kingston Medical Centre staff with a certificate and prize to congratulate them on recruiting the 1000th patient into the MERMAIDS-ARI study are pictured l-r: Dr Brian Osborne, Martha Killilea, HRB Primary Care Clinical Trials Network Ireland, Nurse Paula McGinley and Edel Noone. Photo: NUI Galway
Apr 11 2018 Posted: 16:23 IST

The HRB Primary Care Clinical Trials Network Ireland, based at NUI Galway, is working with researchers in Oxford University on the MERMAIDS Acute Respiratory Infection (ARI) study. It is part of a Europe-wide study across eight countries, which aims to recruit a total of 2,000 participants. The results of this study will help to improve the prevention, treatment and care of patients with these infections.

Acute respiratory infections such as colds, influenza and pneumonia affect millions of people globally each year. The majority of cases are mild, but some people become very ill and are admitted to hospital for treatment.

HRB Primary Care Clinical Trials Network Ireland Director, Professor Andrew Murphy at NUI Galway, said: “It is very important that primary care patients in Ireland are given the opportunity to contribute to significant international studies. We are delighted to see our Network practices exceeding the national recruitment target, and agreeing to continue recruitment in order to contribute to the European target.”

Recruitment in Galway is taking place in Galway University Hospital, GalviaWest Medical Centre in Westside, the Kingston Medical Centre in Knocknacarra, and in County Clare at Ballyvaughan Medical Centre. The willingness of Irish patients and staff to participate in this important study in what is the busiest time of the year in primary care highlights the interest among the Irish public in contributing to answering important healthcare questions. 

The MERMAIDS-ARI study is funded by the European Commission’s FP7 Programme, under a programme set up to support research organisations to undertake research into the care and treatment of emerging infections and to improve European preparedness of these infections.

For more information about the study, contact Martha Killilea, HRB Primary Care Clinical Trials Network, in NUI Galway at martha.killilea@nuigalway.ie or 091-495308.

-Ends-

Marketing and Communications Office

Marketing and Communications Office

PreviousNext

Featured Stories